Imapextide

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameImapextide
Drug Alias NameMBX-1416
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsPost-bariatric HypoglycemiaHypoglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMBX Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesMBX Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPost-bariatric Hypoglycemia
Inactive IndicationsHypoglycemia

Other Information

ATC CodeN/A
Related LinksN/A